Bio-Techne Corporation (TECH) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Bio-Techne Corporation (TECH) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

TECH

Market Closed

Bio-Techne Corporation

NASDAQHealthcare Biotechnology

3.10K employees

CEO: Kim Kelderman

Founded: 1989

$57.94

+$0.00(+NaN%)

Market Cap

9.07B

Beta

1.36

52W Range

N/A

Dividend Yield

0.55%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: Bio-Techne trades 39% above a high-confidence fair value of $35.41, indicating potential overvaluation. Monte Carlo analysis shows high downside risk with median valuation well below current price and significant volatility. Strong liquidity contrasts weak profitability and growth, signaling fundamental challenges amid price premium.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore TECH

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples